IA
NAGE

IFP Advisors’s Niagen Bioscience NAGE Stock Holding History

IFP Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23
Closed -$101 – 5320
2026
Q1 		$101 Sell
23
-72
-76% -$389 ﹤0.01% 4740
2025
Q4 		$604 Sell
95
-168
-64% -$1.17K ﹤0.01% 4234
2025
Q3 		$2.45K Buy
263
+5
+2% +$50 ﹤0.01% 3616
2025
Q2 		$3.92K Buy
+258
New +$2.55K ﹤0.01% 3545
2025
Q1 		– Sell
-2
Closed -$11 – 4687
2024
Q4 		$11 Buy
+2
New +$11 ﹤0.01% 4528

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

IFP Advisors's NAGE Position: Q2 2026 in Review

IFP Advisors sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 23 shares — an estimated $101 sold.

IFP Advisors first reported a position in NAGE in Q4 2024 and held it in 5 quarters. The position peaked at $3.92K in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • IFP Advisors reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 23 Niagen Bioscience shares in Q2 2026, an estimated $101.
  • IFP Advisors first reported a position in Niagen Bioscience in Q4 2024 and held it in 5 quarters.
  • IFP Advisors's Niagen Bioscience position peaked at $3.92K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.